Literature DB >> 23883495

Oncologic specimen from laparoscopic assisted gastrectomy for gastric adenocarcinoma is comparable to D1-open surgery: the experience of a Canadian centre.

Julie Hallet1, Saber Labidi, Antoine Bouchard-Fortier, Ariane Clairoux, Jean-Pierre Gagné.   

Abstract

BACKGROUND: The Eastern experience has reported the safety of laparoscopic assisted gastrectomy (LAG) for gastric cancer. Its use in Western countries is still debated owing to concerns about its oncologic equivalence to open gastrectomy (OG). We sought to review and compare their operative outcomes and oncologic specimen quality (number of harvested lymph nodes and surgical margins) for gastric adenocarcinoma (GA).
METHODS: We reviewed the charts of all patients undergoing LAG (2007-2010) and OG (2000-2010) for GA in a single institution. Several surgeons performed the OGs, whereas 1 fellowship-trained laparoscopic surgeon performed LAGs. The primary outcome was quality of the surgical specimen, assessed by the number of harvested lymph nodes (LNs) and margin status. Secondary outcomes were perioperative events. Data were analyzed as intention to treat.
RESULTS: We retrieved 60 cases (47 OGs, 13 LAGs). The conversion rate was 23%. Mean operative time was 115 minutes longer and blood loss was 425 mL less (both p < 0.001) for LAGs. A mean of 14.4 (standard deviation [SD] 9.8) and 11.2 (SD 8.2) LNs were harvested for OGs and LAGs, respectively (p = 0.29). Negative margins were achieved for all patients. Mean length of stay was similar (LAG: 19 d v. OG: 18.9 d; p = 0.91). The groups did not differ on major postoperative complications (12.7% v. 23.1%; p = 0.39) or operative mortality (2.1% v. 7.7%; p = 0.32).
CONCLUSION: Laparoscopic assisted gastrectomy is a challenging but safe and feasible procedure in experienced hands. It offers the same radical resection as OG regarding negative margins and LN retrieval. Long-term follow-up is warranted.

Entities:  

Mesh:

Year:  2013        PMID: 23883495      PMCID: PMC3728244          DOI: 10.1503/cjs.002612

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  39 in total

1.  Comparison of laparoscopic and open gastrectomy for gastric cancer.

Authors:  J Esteban Varela; Michael Hiyashi; Tien Nguyen; Allen Sabio; Samuel E Wilson; Ninh T Nguyen
Journal:  Am J Surg       Date:  2006-12       Impact factor: 2.565

2.  Gastrectomy and esophagogastrectomy for proximal and distal gastric lesions: a comparison of open and laparoscopic procedures.

Authors:  Valerie Francescutti; Ian Choy; Laurent Biertho; Charles H Goldsmith; Mehran Anvari
Journal:  Surg Innov       Date:  2009-05-25       Impact factor: 2.058

Review 3.  Laparoscopy versus open surgery for advanced and resectable gastric cancer: a meta-analysis.

Authors:  D Martínez-Ramos; J M Miralles-Tena; M A Cuesta; J Escrig-Sos; D Van der Peet; J S Hoashi; J L Salvador-Sanchís
Journal:  Rev Esp Enferm Dig       Date:  2011-03       Impact factor: 2.086

4.  Assessment of open versus laparoscopy-assisted gastrectomy in lymph node-positive early gastric cancer: a retrospective cohort analysis.

Authors:  Ji Yeong An; Geon-Ung Heo; Jae-Ho Cheong; Woo Jin Hyung; Seung Ho Choi; Sung Hoon Noh
Journal:  J Surg Oncol       Date:  2010-07-01       Impact factor: 3.454

5.  Prospective randomized study of open versus laparoscopy-assisted distal gastrectomy with extraperigastric lymph node dissection for early gastric cancer.

Authors:  H Hayashi; T Ochiai; H Shimada; Y Gunji
Journal:  Surg Endosc       Date:  2005-07-28       Impact factor: 4.584

6.  Laparoscopic-assisted resection of a gastric lipoma.

Authors:  A M Lacy; J Tabet; L Grande; J C García-Valdecasas; J Fuster; S Delgado; J Visa
Journal:  Surg Endosc       Date:  1995-09       Impact factor: 4.584

7.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

8.  Long-term oncologic outcomes from laparoscopic gastrectomy for gastric cancer: a single-center experience of 601 consecutive resections.

Authors:  Sang-Woong Lee; Eiji Nomura; George Bouras; Takaya Tokuhara; Souichiro Tsunemi; Nobuhiko Tanigawa
Journal:  J Am Coll Surg       Date:  2010-05-26       Impact factor: 6.113

9.  Does laparoscopic vs. conventional surgery increase exfoliated cancer cells in the peritoneal cavity during resection of colorectal cancer?

Authors:  S H Kim; J W Milsom; T L Gramlich; S M Toddy; G I Shore; J Okuda; V W Fazio
Journal:  Dis Colon Rectum       Date:  1998-08       Impact factor: 4.585

10.  Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.

Authors:  A Cuschieri; S Weeden; J Fielding; J Bancewicz; J Craven; V Joypaul; M Sydes; P Fayers
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

View more
  3 in total

1.  Laparoscopic Compared to Open Repeat Hepatectomy for Colorectal Liver Metastases: a Multi-institutional Propensity-Matched Analysis of Short- and Long-Term Outcomes.

Authors:  Julie Hallet; Antonio Sa Cunha; Daniel Cherqui; Brice Gayet; Diane Goéré; Philippe Bachellier; Alexis Laurent; David Fuks; Francis Navarro; Patrick Pessaux
Journal:  World J Surg       Date:  2017-12       Impact factor: 3.352

2.  Surgical skills for laparoscopic resection of the bursa omentalis and lymph node scavenging with radical gastrectomy.

Authors:  Liao-Nan Zou; Yao-Bin He; Hong-Ming Li; DE-Chang Diao; DE-Long Mo; Wei Wang; Jin Wan
Journal:  Oncol Lett       Date:  2015-05-19       Impact factor: 2.967

Review 3.  Short and long-term outcomes of laparoscopic compared to open liver resection for colorectal liver metastases.

Authors:  Julie Hallet; Kaitlyn Beyfuss; Riccardo Memeo; Paul J Karanicolas; Jacques Marescaux; Patrick Pessaux
Journal:  Hepatobiliary Surg Nutr       Date:  2016-08       Impact factor: 7.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.